Cargando…

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients

BACKGROUND: Oral posaconazole (PCZ) is widely used for both prophylaxis and treatment of invasive fungal infections (IFIs) in adult leukemia patients due to its broad antifungal spectrum. However, issues with PCZ tolerability can result in treatment interruption or discontinuation, and the need for...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiPippo, Adam J, Rausch, Caitlin R, Kontoyiannis, Dimitrios P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255005/ http://dx.doi.org/10.1093/ofid/ofy210.422

Ejemplares similares

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

1719. Incidence and Characterization of Invasive Fungal Infections (IFIs) in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib (IBR)
por: Frei, Michael, et al.
Publicado: (2019)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study
por: Bose, Prithviraj, et al.
Publicado: (2019)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Ruan, Lan-hong, et al.
Publicado: (2021)

Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
por: Buege, Michael J., et al.
Publicado: (2018)

941. Isavuconazole Prophylaxis Against Invasive Fungal Infection: A Pooled Analysis with a Comparison of Posaconazole Delayed-release Tablet Prophylaxis
por: Lee, Chaeryoung, et al.
Publicado: (2021)

Geothermal power plants: principles, applications, case studies and environmental impact
por: DiPippo, Ronald
Publicado: (2016)

Geothermal power plants: principles, applications, case studies and environmental impact
por: DiPippo, Ronald
Publicado: (2008)

Geothermal power plants: principles, applications, case studies and environmental impact
por: DiPippo, Ronald
Publicado: (2012)

Mitochondrial Respiratory Pathways Inhibition in Rhizopus oryzae Potentiates Activity of Posaconazole and Itraconazole via Apoptosis
por: Shirazi, Fazal, et al.
Publicado: (2013)

2110. Treatment of Coccidioidomycosis with Isavuconazole
por: Jamros, Christina, et al.
Publicado: (2019)

Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
por: Li, Julius, et al.
Publicado: (2015)

393. Isavuconazole in the Treatment of Coccidioidal Meningitis
por: Heidari, Arash, et al.
Publicado: (2018)

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
por: Soman, Rajeev, et al.
Publicado: (2022)

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)

2537. Population Pharmacokinetics of Isavuconazole in Pediatric Patients
por: Desai, Amit, et al.
Publicado: (2023)

837. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis
por: Heidari, Arash, et al.
Publicado: (2023)

PHL4/411: Getting Practice on the Internet
por: G. Neville, R, et al.
Publicado: (1999)

Posaconazole-Induced Hypertension and Hypokalemia: Mechanistic Evaluation
por: Thompson, George R, et al.
Publicado: (2017)

381. Morphologic Changes Associated With Echinocandin Tolerance Enhance Immunoevasion of Candida glabrata
por: Hu, Chenlin, et al.
Publicado: (2018)

Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
por: Guest, John, et al.
Publicado: (2017)

1726. Patterns of Isavuconazole Use for Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2022)

Safety, Tolerability, and Pharmacokinetics (PK) of Posaconazole (POS) Intravenous (IV) Solution and Oral Powder for Suspension in Children With Neutropenia
por: Groll, Andreas H, et al.
Publicado: (2017)

Secondary mutations in t(4;11) leukemia patients
por: Prelle, C, et al.
Publicado: (2013)

732. Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism
por: Nguyen, Minh-Vu Hoang, et al.
Publicado: (2019)

819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2023)

Posaconazole: Various toxicities: 2 case reports
Publicado: (2022)

974. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels
por: Pasikhova, Yanina, et al.
Publicado: (2023)

Low-temperature energy systems with applications of renewable energy
por: Redko, Andriy, et al.
Publicado: (2019)

Prolonged Vincristine Toxicity Induced by Concurrent Posaconazole in a Child with T-cell Acute Lymphoblastic Leukemia
por: Alavi, Samin, et al.
Publicado: (2013)

Real-World Use – Isavuconazole at a Large Academic Medical Center
por: Hassouna, HabiBA, et al.
Publicado: (2017)

1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
por: Patterson, Thomas, et al.
Publicado: (2014)

Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
por: Drakulovski, Pascal, et al.
Publicado: (2023)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
por: Zurl, Christoph, et al.
Publicado: (2020)

2571. Posaconazole DRT in Children; Time to Bring Out the Pill Crusher?
por: Weerdenburg, Heather L, et al.
Publicado: (2023)

411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection
por: Reum Kim, A, et al.
Publicado: (2023)

827. Adjunct terbinafine in patients with leukemia and invasive fusariosis with skin lesions: Discordance between responses of skin lesions and systemic outcomes
por: Matsuo, Takahiro, et al.
Publicado: (2023)

1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
por: Kontoyiannis, Dimitrios, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lmsnad4eu90ej62lnjp9avg64k